×
ADVERTISEMENT

gout

Pain Issues Projected to Rise Among Postmenopausal Women

Musculoskeletal disorders are on the rise among postmenopausal women, with particular concern over the rates of ...

JULY 18, 2025

Pharmacists Drive Guidelines-Based Gout Therapy

A pharmacist-driven educational initiative has led to increased use of guideline-based therapy, according to a ...

JANUARY 14, 2022

ED Patients With Gout Flares Too Often Receive Opioids

Patients with gout flares presenting to the emergency department are frequently given opioids or discharged with ...

SEPTEMBER 15, 2020

FDA Approves Liquid Formulation of Gout Drug Colchicine

The FDA has approved the first liquid formulation of a prophylactic gout drug, colchicine oral solution (Gloperba, ...

MARCH 4, 2019

FDA to Review New Drug Application for Gout Drug

Duzallo is a once-daily, fixed-dose combination of lesinurad and allopurinol for the treatment of hyperuricemia ...

JANUARY 4, 2017

New EULAR Gout Guidelines Focus on Uric Acid Reduction

The updated guidelines will hopefully lead to substantial improvements in the management and reduction of painful ...

NOVEMBER 8, 2016

Taking the Sting out of Gout and Comorbid CVD

Gout patients with cardiovascular disease could benefit from earlier and more aggressive urate-lowering therapy, ...

SEPTEMBER 5, 2016

Study: Most Gout Patients Knowledgeable About Condition, Vast Majority Unaware of Numerical Treatment Goals

New research may hold answers as to why gout is so poorly managed in many patients: Although the study participants ...

MAY 10, 2016

FDA Approves Zurampic To Treat Gout

Zurampic carries a boxed warning about a risk for acute kidney failure.

DECEMBER 29, 2015

Load more